Dr. Sadeghi is originally from Iran and received his initial medical training at the Tehran University of Medical Sciences. As an internal medicine faculty at UT Houston, he became interested in cancer care and completed his fellowship in Hematology-Oncology at the University of Texas Southwestern Medical Center. Dr. Sadeghi brings to UTSW a strong background in malignant hematology, breast medical oncology, and medical education. He currently specializes in hematologic malignancies and breast cancer. His clinical practice emphasizes patient and family-centered care.
- Medical School
- Tehran University of Medical Sciences Medical School (1999)
- Internship (Residency)
- The University of Texas Medical Branch at Houston (2005), Internal Medicine
- The University of Texas Medical Branch at Houston (2007), Internal Medicine
- Graduate School
- University of Texas School of Public Health (2010), Epidemiology
- UT Southwestern Medical Center (2013), Hematology Oncology
- Breast cancer
- Leukemia and Lymphoma
- Targeting the PI3K pathway for cancer therapy.
- Sadeghi N, Gerber DE Future Med Chem 2012 Jun 4 9 1153-69
- Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
- Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D Clin. Cancer Res. 2012 May 18 10 2905-12
- American Society of Clinical Oncology (2010)
- American Society of Hematology (2010)
- American College of Physicians (2004)